Privi Speciality Chemicals Limited · NSE:PRIVISCL
Privi Speciality Chemicals — Q3 FY2022 Earnings Presentation
28 slides from Privi Speciality Chemicals's earnings presentation, Jan 28, 2022
Slide 1: Privi Speciality Chemicals Ltd Investor Presentation FY22 (Q3) Earnings
Privi Speciality Chemicals Ltd Investor Presentation FY22 (Q3) Earnings 28 Jan 22 Investor Presentation 1
Slide 2: Content
Content 01 Company Overview 02 Financial Overview 03 Projects Overview Investor Presentation 2
Slide 3: About Privi
About Privi Revenue (Rs lakhs) and EBITDA margin Revenue EBITDA% Fast growing manufacturer of Aroma Chemicals (specialty chemicals 1,60,000 20.99% 22.00% forming key ingredients in formulation of fragrances) 19.33% 1,40,000 17.39% 1,35,047 1,29,652 Global leaders in key products we manufacture 15.48
Slide 4: Industry Overview
Industry Overview • Privi operates in Aroma chemicals (Fragrance Ingredients) market which is a part Flavour and Fragrance (F&F) Industry • Global F&F market size is about USD 30.4 Bn (53%) Flavours (47%) • Fragrance accounts for about USD 16.1 Bn (53%) of the total F&F market • Within Fragrance, Ar
Slide 5: Infrastructure
Infrastructure OPTIMUM PRODUCTION CAPACITY - 37,000 MTPA CST PROCESSING CAPACITY - 36,000 MTPA TOTAL PLANT AREA - 226,500 Sq mt TOTAL REACTION CAPACITY - 500 KL TOTAL DISTILLATION CAPACITY - 900 KL/Day BLENDING CAPACITY - 500 KL STEAM GENERATION - 78 Tons/Hour CONNECTED POWER - 13,40
Slide 6: Content
Content 01 Company Overview 02 Financial Overview 03 Projects Overview Investor Presentation 6
Slide 7: Standalone unaudited financial results
Investor Pry Privi Speciality Chemicals Limited 3 (‘Formerly known as Fairchem Speciality Limited’) 3 » P Regd. Office : Privi House, A-71,TTC Industrial Area,Thane Belapur Road,Kopar Khairane, Navi Mumbai - 400 740, india aid i¢ Email : investors@privi.co.in Phone : #91 22 33043500 / 33043600 Fax :
Slide 8: Standalone Balance Sheet
(Currency: Indian Rupees in lakhs) As at As at STANDALONE BALANCE SHEET December 31, 2021 March 31, 2021 ASSETS Non-current assets Property, plant and equipment 58,226.98 53,949.86 Capital work-in-progress 35,946.19 17,444.95 Right to use assets 2,971.46 1,879.96 Intangible assets 537.15 642.00 Fina
Slide 9: Consolidated unaudited financial results
Investo: Privi Speciality Chemicals Limited CIN ; L15140MHI985PLC286828 {Formerly known as Fairchem Speciality Limited’) Regd, Office ; Privi House, A-71,TTC Industrial Area,Thane Belapur Road, Kopar Khairane, Navi Mumbai - 400 710, India Email : investors@privi.co.in Phone : +91 22 33043500 / 33043
Slide 10: Consolidated Balance Sheet
(Currency: Indian Rupees in lakhs) As at As at Consolidated Balance Sheet December 31, 2021 March 31, 2021 ASSETS Non-current assets Property, plant and equipment 60,147.22 56,014.33 Capital work-in-progress 35,946.19 17,444.95 Right to use assets 4,055.59 3,058.47 Intangible assets 600.36 712.98 In
Slide 11: Financial Highlights: Last Quarters Revenue and Profitability
Financial Highlights Last 3 Quarters Revenue and Profitability Revenue Gross Profit% EBITDA% PBT% 31.24% 39,454 27.40% 26.64% 33,229 30,004 18.89% Rs Lakhs 15.59% 15.32% 11.90% 9.11% 7.99% Jun 21 Sep 21 Dec 21 Jun 21 Sep 21 Dec 21 *Revenue excluding other income ** EBITDA% & PBT% before exceptional
Slide 12: Financial Highlights: Last Quarters ROE, ROCE and Cash Conversion
Financial Highlights Last 3 Quarters ROE ROCE and Cash conversion cycle ROCE ROE Cash Conversion Days 15.81% 127 128 12.72% 12.90% Days 6.82% 10.54% 8.14% 123 Jun 21 Sep 21 Dec 21 Jun 21 Sep 21 Dec 21 Investor Presentation 12
Slide 13: Financial Highlights: Fixed assets, Net worth and Net debt
Financial Highlights Last 3 Quarters Fixed assets, Net worth and Net debt Gross Block (incl CWIP) Net Block (incl CWIP) Net Worth Net Debt 1,60,000 90,000 1,40,000 80,000 1,20,000 70,000 60,000 1,00,000 Rs Lakhs Rs Lakhs 50,000 80,000 40,000 60,000 30,000 40,000 20,000 20,000 10,000 0 0 Jun 21 Sep 2
Slide 14: Financial Highlights: Cumulative 9M Revenue and Profitability
Financial Highlights Cumulative 9M Revenue and Profitability Revenue Gross Profit% EBITDA% PBT% 1,02,687 28.35% 29.12% Rs Lakhs 16.55% 16.30% 92,346 9.68% 8.41% FY22 9M FY 21 9M FY22 9M FY 21 9M *Revenue excluding other income ** EBITDA% & PBT% before exceptional income/loss Investor Presentation 14
Slide 15: Financial Highlights: Cumulative 9M ROE, ROCE and Cash Conversion
Financial Highlights Cumulative 9M ROE ROCE and Cash conversion cycle ROCE ROE Cash Conversion Days 147 11.49% 11.27% 140 10.73% Days 9.59% FY22 9M FY 21 9M FY22 9M FY 21 9M Investor Presentation 15
Slide 16: Financial Highlights: Cumulative 9M Fixed assets, Net worth, Net debt
Financial Highlights Cumulative 9M Fixed assets, Net worth and Net debt Gross Block (incl CWIP) Net Block (incl CWIP) Net Worth Net Debt 1,60,000 90,000 1,40,000 80,000 1,20,000 70,000 60,000 1,00,000 Rs Lakhs Rs Lakhs 50,000 80,000 40,000 60,000 30,000 40,000 20,000 20,000 10,000 0 0 FY22 9M FY 21
Slide 17: Financial Highlight: Volume and Value Segment wise breakup
Financial Highlight Volume and Value Segment wise breakup Actual Volume Actual Sales Pinene Phenol Citral Speciality Pinene Phenol Citral Speciality 949 11,944 1,162 4% 12% 5% 10,136 10% 3,467 16% 7,816 21,805 T 1,02,687 7% Lakhs 72,791 16,226 71% 75% Investor Presentation 17
Slide 18: Content
Content 01 Company Overview 02 Financial Overview 03 Projects Overview Investor Presentation 18
Slide 19: Projects
Projects GALAXMUSK CAMPHOR PRIONYL Capacity -4800 TPA Capacity – 4800 TPA Capacity – 120 TPA Start - April 2022 Start – April 2022 Commissioned – 31 Dec 2021 Location - Jhagadia, Gujarat Location - Mahad, Maharashtra Location - Mahad, Maharashtra Investor Presentation 19
Slide 20: Galaxmusk Project – Process Plant
Galaxmusk Project – Process Plant Investor Presentation
Slide 21: Galaxmusk Project – RM and FG Tank farm
Galaxmusk Project – RM and FG Tank farm Investor Presentation
Slide 22: Galaxmusk Project - ETP Area (RO/UF Plant)
Galaxmusk Project - ETP Area (RO/UF Plant) Investor Presentation
Slide 23: Camphor Project
Camphor Project Piping work ongoing, Commissioning by 31-Mar-22 Investor Presentation
Slide 24: Camphor Project
Camphor Project Investor Presentation
Slide 25: Prionyl Project Commissioned
Prionyl Project Commissioned Investor Presentation
Slide 26: Prionyl Project
Prionyl Project Investor Presentation
Slide 27: Prionyl Project
Prionyl Project Investor Presentation
Slide 28: Thank You
THANK YOU Investor Presentation 28
Privi Speciality Chemicals — Q3 FY2022 Earnings Presentation on 6ix